Summary
The human platelet antigen 1 (HPA‐1) system has been implicated in rare but severe diseases, such as neonatal alloimmune thrombocytopenic purpura, post‐transfusion purpura and immune platelet refractoriness. We developed a flow cytometry assay for HPA‐1 phenotyping using two commercial monoclonal antibodies, P2 and SZ21, directed against glycoprotein (GP) IIb–IIIa and GP IIIa respectively. One hundred and twenty‐seven healthy controls were studied and ratios of mean fluorescence intensity for P2 and SZ21 discriminated between HPA‐1a homozygotes and heterozygotes. These two monoclonal antibodies, coupled with flow cytometry represent a rapid and reliable tool for platelet HPA‐1 typing to aid diagnosis.